Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Cardiovascular Conditions and Diseases
      • Digital Health
      • Health Policy
      • Immunity and Infectious Diseases
      • Joint Health and Mobility
      • Respiratory and Lung Health
      • Spinal Cord Injury and Rehabilitation
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • Ovarian Cancer Research Centre
      • Vancouver Prostate Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • CST Cerner at VCH
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Education and Training
      • Communications and Branding
      • Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Innovation and Partnership
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. ‘Silver bullet’ coating technologies to keep medical devices free of bacteria

‘Silver bullet’ coating technologies to keep medical devices free of bacteria

News Releases Apr 27, 2022 4 minutes

News Release | A safe and highly effective coating that could eliminate implant-associated infections in patients.

Researchers from the Vancouver Coastal Health Research Institute (VCHRI) and University of British Columbia (UBC) have found a ‘silver bullet’ to kill bacteria and keep them from infecting patients who have medical devices implanted.

The team has developed a silver-based coating that can easily be applied to devices such as catheters and stents. Their novel formulation, discovered by screening dozens of chemical components, overcomes the complications of silver that have challenged scientists for years.

“This is a highly effective coating that won’t harm human tissues and could potentially eliminate implant-associated infections. It could be very cost-effective and could also be applicable to many different products,” said Dr. Jayachandran Kizhakkedathu, professor in UBC’s department of pathology and laboratory medicine, Centre for Blood Research and Life Sciences Institute and co-senior author of the study published today in ACS Central Science.

(L-R) Drs. Dirke Lange, Jayachandran Kizhakkedathu and Hossein Yazdani-Ahmadabadi

Implanted medical devices can save lives, but they carry a great risk of infection which usually arises from contamination as the device is being implanted. Urinary tract infections from catheters, for example, are among the most common hospital-acquired infections.

Silver has long been viewed as a potential solution because of its ability to kill bacteria, but its use on implanted devices poses several challenges that have stumped researchers until now. The main challenge is its toxicity. Too much of the poison that kills bacteria can also be bad for human cells and tissues.

Coatings incorporating silver have also proven overly complicated to make, lacked durability, became easily gummed up with proteins or crystals, or simply didn’t adhere well to the surface of devices and implants.

The team led by Dr. Hossein Yazdani-Ahmadabadi, a former chemistry PhD student from the Kizhakkedathu laboratory, combined silver nitrate, dopamine and two hydrophilic polymers to generate the coating. Once implanted, it releases silver ions gradually in small, controlled quantities — enough to kill bacteria but not harm human cells. It repels live and dead bacteria and other fouling agents from its surface, keeping it clean.

It also maintains its killing activity for longer than has been achieved by other coatings.

The researchers tested it for 30 days in an environment with a high concentration of diverse and resilient bacteria known to cause infections. Their device came away with no bacteria attached. In a seven-day test with live rats, it performed the same way and did not harm the rats’ tissues.

“Other silver-based coatings rely on contact killing, meaning the bacteria have to attach to the material in order to be exposed to the silver and die. This results in dead bacteria building up on the surface over time and rendering the device ineffective,” explained the study’s other co-senior author Dr. Dirk Lange, associate professor in UBC’s department of urologic sciences and director of basic science research at the Stone Centre at Vancouver General Hospital. "“We’re preventing that by keeping bacteria off the surface in the first place, and then killing them with the release of silver."

“This coating has significant potential to maintain a clean surface for any device or material for an extended period of time, which is something we haven’t seen so far.”

The coating could be applied to almost any material without pre-treatment used to make medical devices such as central venous catheters, urethral catheters, peritoneal catheters, feeding tubes, vascular grafts, ureteral stents or orthopaedic implants.

Silver is a precious metal, but the amount required is so small that it would add only about 50 cents to the cost of a catheter.

The research team looks forward to seeing how the coating performs in clinical trials, and is optimistic that their discovery could be in wide use to prevent infections in patients within the next decade.

Their work was funded by Canadian Institutes of Health Research, the Natural Sciences and Engineering Council of Canada, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund and the Michael Smith Foundation for Health Research.

Read the original news release on the UBC Faculty of Medicine website.

Researchers

Dirk Lange

Related Articles

Antibiotics taken during labour and delivery not linked to autism

The invisible lightness of healing

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Investigator Awards 2023 Recipients

Mar 21, 2023 award
Type
Stories

Ask an expert: Is my menstrual pain normal, or could I have endometriosis?

Mar 16, 2023 women, endometriosis, preventative
Type
Stories

Honing in on precision treatments for endometriosis

Mar 14, 2023 genetics, treatment options
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • Twitter
  • LinkedIn

© 2023 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy